[Thermosensitization of tumor cells with inhibitors of chaperone activity and expression]

Area of Science:

• Cellular Biology
• Oncology
• Molecular Medicine

Background:

• Heat shock proteins (HSPs) are crucial for cellular stress response and survival.
• HSP90 is a key chaperone involved in protein folding and stability.
• Cancer cells often rely on HSPs for survival and proliferation.

Purpose of the Study:

• To investigate the combined effects of HSP90 activity inhibitors and HSP expression inhibitors on the sensitivity of HeLa tumor cells to hyperthermia.
• To explore the potential of targeting both HSP90 function and expression to enhance cancer therapy.

Main Methods:

• HeLa cells were treated with HSP90 inhibitors (17AAG, radicicol) and/or HSP expression inhibitors (quercetin, triptolid, NZ28).
• Cells were exposed to heat stress (43°C for 60 min).
• Reporter assays (luciferase) and cell death assays were used to assess cellular response.

Main Results:

• HSP90 inhibitors alone slowed reporter reactivation and slightly increased cell death, while paradoxically inducing more HSPs.
• Combining HSP90 inhibitors with HSP expression inhibitors prevented chaperone induction.
• The triple treatment (HSP90 inhibitor + HSP expression inhibitor + heat stress) significantly enhanced cell death (2-3 fold) by creating a 'chaperone deficiency'.

Conclusions:

• Simultaneous inhibition of HSP90 activity and HSP expression creates a synergistic vulnerability in tumor cells.
• This 'chaperone deficiency' approach markedly enhances hyperthermia-induced cytotoxicity.
• Targeting both constitutive HSP90 function and inducible HSP expression represents a promising strategy for improving cancer treatment outcomes.